Dana-Farber's Weapon Against COVID-19
New findings prompt the launch of a human clinical trial for a chemically stabilized coronavirus peptide.
Source: medindia.net
Stay updated with breaking news from Gregory Bird. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New findings prompt the launch of a human clinical trial for a chemically stabilized coronavirus peptide.
Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.
• Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of COVID-19 in tests with hamsters